PharmacotherapeuticsforAdvanced PracticeNurse Prescribers, 6th Edition
ko ko ko ko ko ko ko
Author:Teri Moser Woo and WendyL. Wright
ko ko ko ko ko ko ko
, TABLE OF CONTENT ko ko
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber............................................................................ 4
ko ko ko ko ko ko ko ko ko ko
Chapter 2. Review of Basic Principles of Pharmacology .......................................................................................... 5
ko ko ko ko ko ko ko
Chapter 3. Rational Drug Selection ....................................................................................................................... 11
ko ko ko ko
Chapter 4. Legal and Professional Issues in Prescribing ......................................................................................... 14
ko ko ko ko ko ko ko
Chapter 5. Adverse Drug Reactions ...................................................................................................................... 16
ko ko ko ko
Chapter 6. An Introduction to Pharmacogenomics................................................................................................. 19
ko ko ko ko ko
Chapter 7. Nutrition and Nutraceuticals ................................................................................................................ 22
ko ko ko ko
Chapter 8. Herbal Therapies.................................................................................................................................. 28
ko ko ko
Chapter 9. Cannabis.............................................................................................................................................. 31
ko ko
Chapter 10. Pharmacoeconomics .......................................................................................................................... 35
ko ko
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................... 38
ko ko ko ko ko ko ko
Chapter 12. Drugs Affecting the Central Nervous System...................................................................................... 45
ko ko ko ko ko ko ko
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems...................................................................... 53
ko ko ko ko ko ko ko ko
Chapter 14. Drugs Affecting the Respiratory System............................................................................................. 61
ko ko ko ko ko ko
Chapter 15. Drugs Affecting the Hematological System ........................................................................................ 65
ko ko ko ko ko ko
Chapter16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................... 69
ko ko ko ko ko ko ko ko ko
Chapter17. Drugs Affecting the Immune System: Immunomodulators ................................................................. 75
ko ko ko ko ko ko ko
Chapter 18. Drugs Affecting the Gastrointestinal System ...................................................................................... 77
ko ko ko ko ko ko
Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormonesand Antidiabetic Drugs .......................... 80
ko ko ko ko ko ko ko ko ko ko ko
Chapter20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................... 83
ko ko ko ko ko ko ko ko ko ko ko
Chapter 21. Drugs Affecting the Reproductive System .......................................................................................... 86
ko ko ko ko ko ko
Chapter 22. Drugs Affecting the Bones and Joints ................................................................................................. 92
ko ko ko ko ko ko ko
Chapter 23. Drugs Affecting the Integumentary System ........................................................................................ 96
ko ko ko ko ko ko
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................... 101
ko ko ko ko ko ko ko
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections.............................................................. 105
ko ko ko ko ko ko ko ko ko ko
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................... 108
ko ko ko ko ko ko ko
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ....................................................................................... 111
ko ko ko ko ko ko ko ko ko
Chapter 28. Anemia ............................................................................................................................................ 113
ko ko
Chapter 29. Anxiety and Depression ................................................................................................................... 116
ko ko ko ko
Chapter 30. Attention Deficit-Hyperactivity Disorder ........................................................................................ 120
ko ko ko ko
Chapter 31. Asthma and Allergy ......................................................................................................................... 122
ko ko ko ko
Chapter 32. Chronic Obstructive Pulmonary Disease .......................................................................................... 125
ko ko ko ko ko
Chapter 33. Contraception .................................................................................................................................. 127
ko ko
Chapter 34. COVID-19: Acute and Chronic ........................................................................................................ 130
ko ko ko ko ko
Chapter 35. Dermatological Conditions .............................................................................................................. 134
ko ko ko
Chapter 36. Diabetes Management ..................................................................................................................... 138
ko ko ko
Chapter37. Gastroesophageal Reflux and Peptic Ulcer Disease .......................................................................... 146
ko ko ko ko ko ko ko
Chapter 38. Headaches ....................................................................................................................................... 149
ko ko
Chapter 39. Heart Failure .................................................................................................................................... 153
ko ko ko
Chapter40. HIV Disease and Acquired Immunodeficiency Syndrome ................................................................ 158
ko ko ko ko ko ko ko
Chapter 41. Menopausal Hormone Therapy ........................................................................................................ 161
ko ko ko ko
,Chapter 42. Hyperlipidemia................................................................................................................................ 164
ko ko
Chapter 43. Hypertension ................................................................................................................................... 169
ko ko
Chapter 44. Hyperthyroidism and Hypothyroidism............................................................................................. 174
ko ko ko ko
Chapter 45. Obesity ............................................................................................................................................ 177
ko ko
Chapter 46. Pain Management: Acute and Chronic Pain ...................................................................................... 181
ko ko ko ko ko ko ko
Chapter 47. Pneumonia....................................................................................................................................... 185
ko ko
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................... 187
ko ko ko ko ko ko
Chapter 49. Substance Use Disorders .................................................................................................................. 190
ko ko ko ko
Chapter 50. Tuberculosis .................................................................................................................................... 195
ko ko
Chapter51.UpperRespiratoryTract Infection, Pharyngitis,Sinusitis,OtitisMedia, and Otitis Externa .................. 197
ko ko ko ko ko ko ko ko ko ko ko ko
Chapter 52. Urinary Tract Infections ................................................................................................................... 200
ko ko ko ko
Chapter 53. Women as Patients ........................................................................................................................... 203
ko ko ko ko
Chapter 54. Men as Patients ................................................................................................................................ 207
ko ko ko ko
Chapter 55. Pediatric Patients ............................................................................................................................. 209
ko ko ko
Chapter 57. Geriatric Patients ............................................................................................................................. 213
ko ko ko
, Woo 1
PharmacotherapeuticsforAPN Prescribers,6e ko ko ko ko Ch01
Chapter1.The Role ofthe Advanced PracticeNurse asPrescriber
ko ko ko ko ko ko ko ko ko ko
MULTIPLE CHOICE ko
1. Nurse practitioner prescriptive authority is regulated by:
ko ko ko ko ko ko
A. The National Council of State Boards ofNursing ko ko ko ko ko ko ko
B. The U.S. Drug Enforcement Administration ko ko ko ko
C. The State Board of Nursing for each state ko ko ko ko ko ko ko
D. The State Board of Pharmacy ko ko ko ko
ANS: k o C PTS: k o k o 1
2. Thebenefitstothepatientofhaving anadvanced practice registerednurse(APRN)prescriber
ko ko ko ko ko ko ko ko ko ko ko ko ko
ko include:
A. Nursesknowmoreabout pharmacologythanotherprescribersbecausetheytakeit both
ko ko ko ko ko ko ko ko ko ko ko ko
in their basic nursing program and in their APRN program.
ko ko ko ko ko ko ko ko ko ko
B. Nurses careforthepatientfroma holistic approach and includethepatient in
ko ko ko ko ko ko ko ko ko ko ko ko ko
decision-making regarding their care.
ko ko ko ko
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
ko ko ko ko ko ko ko ko ko ko
D. APRNs areabletoprescribeindependentlyinallstates,whereas aphysician’s ko ko ko ko ko ko ko ko ko ko ko
assistant needs to have a physician supervising their practice.
ko ko ko ko ko ko ko ko ko
ANS: k o B PTS: k o k o 1
3. Clinical judgment in prescribing includes: ko ko ko ko
A. Factoring in the cost to the patient of the medication prescribed ko ko ko ko ko ko ko ko ko ko
B. Always prescribing the newest medication available for the diseaseprocess ko ko ko ko ko ko ko ko ko
C. Handing out drug samples to poor patients ko ko ko ko ko ko
D. Prescribing all generic medications to cutcosts ko ko ko ko ko ko
ANS: k o A PTS: k o k o 1
4. The process for choosing an effective drug for a disorderincludes:
ko ko ko ko ko ko ko ko ko ko
A. Asking the patient what drug they think would work best for them ko ko ko ko ko ko ko ko ko ko ko
B. Consulting nationally recognized guidelines for diseasemanagement ko ko ko ko ko ko
C. Prescribingmedications thatare available as samples beforewriting a prescription ko ko ko ko ko ko ko ko ko ko
D. Following U.S. Drug Enforcement Administration guidelines forprescribing ko ko ko ko ko ko ko
ANS: k o B PTS: k o k o 1
5. Nonintentional nonadherence of drug therapy may occur due to: ko ko ko ko ko ko ko ko
A. Belief that medication does not work ko ko ko ko ko
B. Adverse drug reactions ko ko
C. Chronic conditions that require dailytherapy ko ko ko ko ko
D. Forgetfulness ordistraction ko ko
ANS: k o D PTS: k o k o 1